LMV-601

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameLMV-601
Drug Alias NameSPK-0601LMV-601SPK-601
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylcholine-specific phospholipase C inhibitors
TargetsPhosphatidylcholine-specific phospholipase C
Therapy Area/IndicationsPapillomavirus InfectionsHerpes Simplex
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBiosphings
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLumavitaBiosphings
Active IndicationsN/A
Inactive IndicationsPapillomavirus InfectionsHerpes Simplex

Other Information

ATC CodeN/A
Related LinksN/A